Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.

UBS has raised its 2026 sales forecast for Neurocrine's Ingrezza to $2.80 billion, citing potential gains from rival drug coverage changes a

Corn futures jumped after the USDA reported tighter US corn supplies, with 2026 plantings down and June 1st inventories below expectations.

KKR shares rose after The Information reported its Nvidia-backed Helix Infrastructure Partners is exploring a deal for a data center operato

Canada's dollar held steady near 70.40 US cents on Tuesday, but it's still down 2.9% in June. Investors are focused on a widening Canada-US

The S&P 500 and Nasdaq are poised for their best quarter in six years, driven by resilient earnings and economic data. This comes despite ma

Stellantis has paused plans for a new South African factory in Gqeberha, citing a surge in lower-priced Asian imports that has shifted local

The FTSE 100 ended the quarter with a modest gain as investors digested confirmed UK growth of 0.6% in the first quarter. Sainsbury's shares

Zoom is rolling out AI in three tiers, from free meeting summaries to a $20-per-user-per-month ZoomMate add-on. RBC Capital Markets believes

Graham's defense and space backlog surged 29% in fiscal 2026, with new orders still outpacing shipments. Oppenheimer sees $50 million in upg

Nestlé says some parents may not return after pulling baby formula over possible cereulide contamination. The food giant warns it could take

Morgan Stanley says Alphabet's AI compute plan is becoming clearer, with potential to add 9 gigawatts of capacity by 2028 and sell 4 gigawat

US movie theaters are set for their best post-COVID second quarter, with June ticket sales projected at $1.05 billion. However, AMC's latest